• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Elevance Health Inc.

    6/20/24 2:26:17 PM ET
    $ELV
    Medical Specialities
    Health Care
    Get the next $ELV alert in real time by email
    11-K 1 elv-12312023x11k.htm 11-K Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 11-K
    (Mark One)
    xANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2023
    OR
    oTRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from ________to_________
    Commission file number: 001-16751 
     
    A.Full title of the plan and the address of the plan, if different from that of the issuer named below:
    ELEVANCE HEALTH 401(k) PLAN
    B.Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
    Elevance Health, Inc.
    220 Virginia Avenue
    Indianapolis, IN 46204



    REQUIRED INFORMATION
    The Elevance Health 401(k) Plan (the “Plan”) is subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). In lieu of the requirements of Items 1-3 of Form 11-K, the financial statements of the Plan and the supplemental schedule presented herein have been prepared in accordance with the financial reporting requirements of ERISA.
    1


    ELEVANCE HEALTH 401(k) PLAN
    Financial Statements and Supplemental Schedule
    December 31, 2023 and 2022 and for the
    Year Ended December 31, 2023
    With Report of Independent Registered Public Accounting Firm



    ELEVANCE HEALTH 401(k) PLAN
    Financial Statements and Supplemental Schedule
    December 31, 2023 and 2022 and for the
    Year Ended December 31, 2023
    Contents
     Page
    Report of Independent Registered Public Accounting Firm
    4 
    Audited Financial Statements:
    Statements of Net Assets Available for Benefits
    5 
    Statement of Changes in Net Assets Available for Benefits
    6 
    Notes to Financial Statements
    7 
    Supplemental Schedule:
    Schedule H, Line 4i – Schedule of Assets (Held at End of Year)
    13 

    3


    Report of Independent Registered Public Accounting Firm
    To the Plan Participants and the Plan Administrator of the Elevance Health 401(k) Plan

    Opinion on the Financial Statements
    We have audited the accompanying statements of net assets available for benefits of Elevance Health 401(k) Plan (the Plan) as of December 31, 2023 and 2022, and the related statement of changes in net assets available for benefits for the year ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2023 and 2022, and the changes in its net assets available for benefits for the year ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.
    Basis for Opinion
    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
    Supplemental Schedules Required by ERISA
    The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2023, (referred to as the “supplemental schedule”), has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedule is the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.
    /s/ Ernst & Young LLP
    We have served as the Plan’s auditor since at least 2002, but we are unable to determine the specific year.
    Indianapolis, Indiana
    June 20, 2024
    4


    Elevance Health 401(k) Plan
    Statements of Net Assets Available for Benefits
     December 31
     20232022
    Assets
    Investments at fair value$10,818,911,905 $9,275,758,446 
    Receivables:
    Notes receivable from participants211,577,041 181,743,621 
    Contributions receivable from employer12,633,466 11,041,437 
    Net assets available for benefits$11,043,122,412 $9,468,543,504 
    See accompanying notes.

    5


    Elevance Health 401(k) Plan
    Statement of Changes in Net Assets Available for Benefits
    Year Ended December 31, 2023
    Additions to net assets attributable to:
    Contributions:
    Participants562,766,448 
    Rollovers83,650,620 
    Employer305,504,065 
                 Total contributions951,921,133 
    Net appreciation in fair value of investments1,497,247,643 
    Interest and dividends33,140,306 
    Interest income on notes receivable from participants11,923,793 
                Total additions2,494,232,875 
    Deductions from net assets attributable to:
    Benefit payments and withdrawals946,860,058 
    Administrative fees6,170,309 
                Total deductions953,030,367 
    Increase in net assets prior to mergers and transfers1,541,202,508 
    Mergers and transfers of assets, net33,376,400 
    Net assets available for benefits:
    Beginning of year9,468,543,504 
    End of year$11,043,122,412 
    See accompanying notes.

    6


    Elevance Health 401(k) Plan
    Notes to Financial Statements
    December 31, 2023
    1. Description of the Plan
    The following description of the Elevance Health 401(k) Plan (the “Plan”) provides only general information. More detailed information concerning the Plan may be found by consulting the summary plan description, which is available from the Plan Administrator, the Retirement Committee of ATH Holding Company, LLC. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).
    General
    The Plan is a defined contribution plan which was established to provide savings opportunities for eligible employees of Elevance Health, Inc. (“Elevance Health”) and certain of its subsidiaries (the “Participating Employers”). Employees of the Participating Employers are generally eligible to participate 30 days after their date of hire. The Plan Sponsor is ATH Holding Company, LLC, a wholly owned subsidiary of Elevance Health. Fidelity Management Trust Company is the trustee of the Plan and Fidelity Workplace Services LLC is the recordkeeper of the Plan (collectively, "Fidelity").

    Plan Mergers and Transfers
    Effective January 1, 2023, the IEC Group 401(k) Plan ("AmeriBen Plan") was merged into the Plan. As a result of the merger, net assets available for benefits of approximately $30.8 million were transferred from the AmeriBen Plan to the Plan. In addition, other transfers of a lesser extent also occurred during 2023.

    Participant Accounts
    Individual accounts are maintained by the Plan for each eligible employee who participates in the Plan. Each participant’s account is credited with the participant’s contributions, rollover contributions, allocations of the Plan Sponsor’s contributions, and an allocation of investment earnings or losses, reduced by participant withdrawals and certain administrative fees. The investment of participant accounts is participant-directed. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s account.
    Contributions
    Participants may make voluntary contributions of 1% to 80% of eligible compensation, as defined in the Plan document, subject to limitations imposed by applicable Internal Revenue Service (“IRS”) regulations. Participants may make pretax contributions to a traditional 401(k) account, after-tax contributions to a Roth 401(k) account or a combination of the two through automatic payroll deduction. Participants are automatically enrolled in the Plan at an initial pretax deferral rate of 6%, with an annual automatic increase of the rate of 1%, up to 15% of compensation, unless the participant directs otherwise.
    The Plan Sponsor provides a matching contribution of 100% of the first 4% of the participant's eligible compensation contributed in participant pretax or Roth contributions, then 50% of the next 2% of the participant's eligible compensation contributed, for a total potential Plan Sponsor matching contribution of 5%. The Plan Sponsor matching contribution is contributed as a pretax contribution. The Plan permits additional Plan Sponsor discretionary contributions to be made, but no such discretionary contributions were made during the 2023 plan year.
    Participants who attain age 50 by the end of the plan year may elect to contribute additional "catch up" contributions to their account beyond the regular annual IRS limit, in accordance with applicable laws and the Plan's terms. Catch-up contributions are eligible for matching contributions.

    7


    Elevance Health 401(k) Plan
    Notes to Financial Statements (continued)
    Rollover Contributions
    The Plan may accept rollover contributions. Rollover contributions represent distributions received from other qualified retirement plans, as defined in section 401(a)(31)(E) of the Internal Revenue Code (the "Code"), including any such distributions contributed via a "conduit" individual retirement account. Distributions from other plans are subject to certain conditions to be eligible for rollover into the Plan.
    Vesting
    Participants have a vested interest in the Plan Sponsor match after completing a two-year period of service. Nonvested account balances of terminated employees are forfeited (subject to reinstatement upon reemployment as required by applicable law and the Plan's terms).
    Investments
    Participants direct their elective contributions and employer matching contributions into various investment options offered by the Plan, including target date funds, several mutual and collective investment trust funds, all of which are subject to change from time to time by the Plan Administrator, and the Elevance Health Stock Fund, which is provided for in the Plan document and overseen by an independent fiduciary. The Plan also provides access to a self-directed brokerage window. The Plan’s qualified default investment alternative (the applicable target date fund based on the year the participant attains age 65) applies to any amounts for which a participant has not made an affirmative investment election.
    Benefit Payments and Withdrawals
    A participant may make a withdrawal of voluntary after-tax contributions made to a traditional 401(k) account prior to January 1, 2012, or take a qualified distribution of Roth 401(k) contributions, as defined by the IRS, at any time. Additionally, after attaining age 59½, a participant may withdraw participant and Plan Sponsor matching contributions for any reason.
    An active participant in the Plan may make an in-service hardship withdrawal of amounts held in the participant’s account attributable to the participant’s contributions, rollovers, pre-2006 employer match, and income allocated to the contributions account. The in-service hardship withdrawal must be necessary to satisfy an immediate and heavy financial need of the participant due to one of six causes specified by the Plan.
    Upon termination of employment, the participant is entitled to receive the fully vested current value of his or her account. If the current value of the vested account is $1,000 or less, the account is paid in a lump-sum payment. If the vested account value is $1,000 or more, but less than $5,000, the account will be rolled over into an IRA unless the participant elects otherwise. If the vested account value is $5,000 or more, the account will remain in the Plan unless the participant elects otherwise. The participant may elect to have the entire portion, if any, of the account held in the Elevance Health Stock Fund paid in whole shares of Elevance Health common stock, with fractional shares and any uninvested funds paid in cash. Distribution of participant accounts must commence by the later of retirement or the latest date permitted under the Code Section 401(a)(9), as amended by federal legislation known as the SECURE Act and SECURE 2.0 (including regulatory guidance issued thereunder). Upon death, payments are made to the participant’s beneficiary in the form of a lump-sum payment or in installments.
    Notes Receivable from Participants
    Participants may request a loan not in excess of the lesser of: (1) 50% of the vested account balance, or (2) $50,000, less the highest outstanding loan balance during the preceding year. A participant may not have more than two loans outstanding at any one time and must wait 30 days from when a loan is paid off before requesting a new loan. Repayment of loans shall not exceed five years, except for loans used to acquire the participant’s principal residence. Each loan bears interest in accordance with the Plan's loan policy and applicable regulations. Repayments are made by payroll deduction or remitted directly to Fidelity.

    8


    Elevance Health 401(k) Plan
    Notes to Financial Statements (continued)
    Administrative Expenses
    Certain expenses of maintaining the Plan are paid by the Plan. The Plan Sponsor may bear certain costs associated with administering the Plan; these costs are not included in the accompanying financial statements and constitute exempt party-in-interest transactions. Certain transaction fees, such as those related to loan processing, are paid from individual participant accounts. Investment related expenses are included in net appreciation (depreciation) in fair value of investments.
    Forfeitures
    Forfeited nonvested account balances and unclaimed distributions totaled $344,785 and $631,082 as of December 31, 2023 and 2022, respectively. Forfeitures are used as directed by the Plan Sponsor to reduce future employer contributions or to pay certain administrative expenses. During 2023, forfeitures of $9,558,247 were used to offset employer contributions and forfeitures of $281,982 were used to pay administrative expenses.
    Plan Termination    
    Although it has not expressed any intent to do so, the Plan Sponsor has the right to terminate the Plan subject to the terms of ERISA. In the event the Plan is terminated, each participant’s account shall be non-forfeitable with respect to both the participant’s and the Plan Sponsor’s contributions, and the net assets are to be set aside for the payment of withdrawals to the participants. The Plan Sponsor has the right to amend the Plan or to suspend matching contributions to the Plan at any time, either permanently or temporarily, for any length of time.
    2. Significant Accounting Policies
    Basis of Presentation
    The accompanying financial statements of the Plan have been prepared on the accrual basis of accounting and are in conformity with accounting principles generally accepted in the United States (“GAAP”). Accordingly, contributions to the Plan and interest and dividend income are recognized as earned, and realized gains and losses and net unrealized appreciation (depreciation) of fair value of investments are recognized as they occur. Plan benefit payments and withdrawals are recognized when paid.
    Use of Estimates
    The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates.
    Investment Valuation and Income Recognition
    The Plan investments are recorded at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 4 for further discussion of fair value measurements.
    Purchases and sales of securities are recorded on a trade-date basis and interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. Net appreciation or depreciation includes realized gains and losses on investments that were both purchased and sold during the period as well as unrealized appreciation or depreciation of the investments held at year end.
    Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, participant accounts and the statement of changes in net assets available for benefits.


    9


    Elevance Health 401(k) Plan
    Notes to Financial Statements (continued)
    Notes Receivable from Participants
    Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. No allowance for credit losses has been recorded as of December 31, 2023 or 2022.
    3. Employee Stock Ownership Plan ("ESOP")
    The portion of the Plan invested in the Elevance Health Stock Fund is designated as an ESOP. Elevance Health common stock is purchased by the ESOP using participant directed contributions. The Elevance Health Stock Fund is a unitized fund, which means participants do not actually own shares of Elevance Health common stock but rather own an interest in the unitized fund. A portion of the fund may also be invested in short-term reserves to accommodate daily transactions.
    Investment in the Elevance Health Stock Fund is limited to no more than 20% of a participant's total balance. Each participant is entitled to exercise voting rights attributable to the shares allocated to his or her account.
    Put Option
    In accordance with IRS regulations, Elevance Health common stock that ceases to be readily tradable on an established market includes a put option for any participant who is otherwise entitled to a total distribution from the Plan. The put option is the right to require that the Plan Sponsor repurchase the Elevance Health stock credited to the participant’s account under a fair valuation formula. The distribution may be paid with interest over a period of not more than five years.
    Dividends Paid on Elevance Health Common Stock
    Any cash dividends paid to the participant’s account will be reinvested in the Elevance Health Stock Fund unless the participant elects to receive the dividend in cash paid directly to the participant. Participants may change their election to receive dividends in cash or to reinvest dividends at least quarterly.
    4. Fair Value Measurements
    Investments recorded at fair value in the statements of net assets available for benefits are categorized based on the level of judgment associated with the inputs used to measure their fair value. Level inputs, as defined by the Financial Accounting Standards Board ("FASB") guidance for fair value measurements and disclosures, are as follows: Level 1, which refers to securities valued using unadjusted quoted prices from active markets for identical assets; Level 2, which refers to securities not traded on an active market but for which observable market inputs are readily available; and Level 3, which refers to securities valued based on significant unobservable inputs. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
    The following methods and assumptions were used to determine the fair value of investments recorded at fair value in the statements of net assets available for benefits.
    Mutual funds: Valued at quoted market prices, which represent net asset value ("NAV") of shares held by the Plan at year end.
    Elevance Health common stock: Valued at the closing price on the New York Stock Exchange on the last business day of the Plan year.
    Self-directed brokerage accounts: Valued at quoted market prices of the investments held in the brokerage account. Equity securities held in the brokerage account are valued at quoted market prices reported on the active market on which the individual securities are traded on the last business day of the Plan year. Mutual funds are valued at quoted market prices, which represent the NAV of shares held in the brokerage account at year end.
    10


    Elevance Health 401(k) Plan
    Notes to Financial Statements (continued)
    Collective investment trusts (CITs): Valued using the NAV per share as reported by the fund managers. NAV is based on the fair value of the underlying investments within the portfolio. NAV is used as a practical expedient to estimate fair value. The target retirement CITs provide an appropriate asset mix for a participant given the participant’s age and retirement year. The institutional index and other CITs seek to replicate the performance of certain prominent benchmark indexes. There are no restrictions on redemptions from the CITs and no unfunded commitments.
    A summary of the Plan's financial assets carried at fair value on a recurring basis is as follows:

    December 31, 2023TotalLevel ILevel IILevel III
    Mutual funds$388,444,173 $388,444,173 $— $— 
    Elevance Health common stock570,847,321 570,847,321 — — 
    Self-directed brokerage accounts167,373,785 167,373,785 — — 
    Investments measured at fair value1,126,665,279 $1,126,665,279 $— $— 
    Collective investment trusts *9,692,246,626 
    Total investments at fair value$10,818,911,905 
    December 31, 2022TotalLevel ILevel IILevel III
    Mutual funds$413,545,025 $413,545,025 $— $— 
    Elevance Health common stock661,915,399 661,915,399 — — 
    Self-directed brokerage accounts106,077,911 106,077,911 — — 
    Investments measured at fair value1,181,538,335 $1,181,538,335 $— $— 
    Collective investment trusts *8,094,220,111 
    Total investments at fair value$9,275,758,446 
    * In accordance with FASB guidance, the collective investment trusts have not been classified in the fair value hierarchy as they are measured at fair value using NAV as a practical expedient. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the investments at fair value line item in the statements of net assets available for benefits.
    5. Exempt Related Party and Party-In-Interest Transactions
    Parties-in-interest are defined under Department of Labor regulations as any fiduciary of the Plan, any party rendering services to the Plan, the employer, and certain others. Certain administrative functions are performed by officers and employees of the Plan Sponsor or affiliates of the Plan Sponsor. No such officer or employee is compensated from the Plan.
    Transactions in shares of Elevance Health common stock qualify as exempt party-in-interest transactions under the provisions of ERISA. As of December 31, 2023, the Plan owned approximately 1,210,551 shares of Elevance Health common stock. During 2023, the Plan had net sales of Elevance Health common stock totaling $40,381,821.
    As described in Note 1 above, Fidelity Management Trust Company is a directed trustee of the Plan and Fidelity Workplace Services LLC serves as the recordkeeper to maintain the individual accounts of each Plan participant. Certain Plan investments include funds that are managed by affiliates of Fidelity, which constitute party-in-interest transactions.
    Notes receivable from participants also reflect exempt party-in-interest transactions.



    11


    Elevance Health 401(k) Plan
    Notes to Financial Statements (continued)
    6. Income Tax Status
    The Plan has received a determination letter from the IRS dated October 24, 2017, stating the Plan and related trust are qualified under Section 401(a) of the Code, and therefore, exempt from taxation. Although the Plan has been restated and amended since receiving the determination letter, the Plan Sponsor believes the Plan is designed and being operated in compliance with the applicable requirements of the Code.

    GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the IRS. Plan management has analyzed the tax positions taken by the Plan, and has concluded there are no uncertain positions taken or expected to be taken. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.
    7. Reconciliation to Form 5500
    Reconciliation of net assets available for benefits per the financial statements to the Form 5500 as of December 31, 2023 and 2022, is as follows:
    20232022
    Net assets available for benefits per the financial statements$11,043,122,412 $9,468,543,504 
    Deemed distributions of participant loans(730,212)(637,942)
    Net assets available for benefits per the Form 5500$11,042,392,200 $9,467,905,562 

    Reconciliation of the increase in net assets available for benefits per the financial statements to the net income (loss) per the Form 5500 for the year ended December 31, 2023 is as follows:
    2023
    Increase in net assets prior to mergers and transfers per the financial statements$1,541,202,508 
    Deemed distributions activity(92,270)
    Net income (loss) per the Form 5500$1,541,110,238 
    8. Subsequent Events
    The Plan Sponsor has evaluated the impact of subsequent events through June 20, 2024, the date the financial statements were available to be issued. No subsequent events have been recognized or required additional disclosure in the financial statements.
    12


    Elevance Health 401(k) Plan
    Schedule H, Line 4i—Schedule of Assets (Held at End of Year)
    EIN #11-3713086 Plan #003
    December 31, 2023
    (a)(b)(c)(e)
     Identity of issuer, borrower,
    lessor, or similar party
    Description of investment including maturity date,
    interest rate, collateral and par or maturity value
    Current
    value
    The Vanguard Group Mutual Funds
    Explorer Fund Admiral Shares225,595,027 
    Cash Reserves Federal Money Market Fund Admiral Shares1,239,324 
    $226,834,351 
    The Vanguard Group Collective Investment Trusts
    Institutional 500 Index Trust1,568,116,060 
    Retirement Savings Trust II669,625,645 
    Institutional Total Bond Market Index Trust640,905,957 
    Institutional Extended Market Index Trust572,851,632 
    Institutional Total International Stock Market Index Trust415,798,011 
    Target Retirement Income Trust 152,092,268 
    Target Retirement 2020 Trust 161,971,585 
    Target Retirement 2025 Trust 547,248,843 
    Target Retirement 2030 Trust 465,176,106 
    Target Retirement 2035 Trust 769,222,845 
    Target Retirement 2040 Trust 480,661,694 
    Target Retirement 2045 Trust 638,533,801 
    Target Retirement 2050 Trust 396,678,383 
    Target Retirement 2055 Trust 235,488,020 
    Target Retirement 2060 Trust 88,850,975 
    Target Retirement 2065 Trust 17,971,340 
    Target Retirement 2070 Trust3,176,485 
    $7,824,369,650 
    Other Mutual Funds
    Westwood SmallCap Fund; Ultra Shares126,056,291 
    DoubleLine Flexible Income Fund Class I31,680,374 
    *Fidelity Investments Money Market Government Portfolio3,873,157 
    $161,609,822 
    Other Collective Investment Trusts
    T. Rowe Price Large-Cap Growth Trust850,904,466 
    MFS Large Cap Value CIT Class 5417,945,900 
    MFS International Equity Fund Class 3A375,635,721 
    Prudential Core Plus Bond Fund Class 5152,353,935 
    State Street Real Asset Fund Class C71,036,954 
    $1,867,876,976 
    *Elevance Health common stock570,847,321 
    **Self-directed brokerage accounts167,373,785 
    *Notes receivable from participantsInterest rates range from 3.25% to 10.5%, maturing at various dates through 2047210,846,829 
    $11,029,758,734 
    * Party-in-interest.
    ** Certain investments in the self-directed brokerage accounts are issued by a party-in-interest
    Note: As all investments are participant directed, column (d) is not applicable and has been eliminated.
    13


    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Retirement Committee of ATH Holding Company, LLC has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
             ELEVANCE HEALTH 401(k) PLAN
    By:/s/ Ronald W. Penczek
    Ronald W. Penczek
    Member, Retirement Committee
    of ATH Holding Company, LLC
    Date: June 20, 2024

    14


    EXHIBIT INDEX
    Exhibit NumberDescription
    23Consent of Independent Registered Public Accounting Firm









    15
    Get the next $ELV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELV

    DatePrice TargetRatingAnalyst
    2/3/2026$358.00Outperform → Sector Perform
    RBC Capital Mkts
    1/8/2026$425.00Peer Perform → Outperform
    Wolfe Research
    12/19/2025$320.00Buy → Hold
    Deutsche Bank
    10/14/2025Neutral
    Goldman
    7/21/2025Buy → Hold
    Argus
    7/18/2025$310.00Outperform → Market Perform
    Leerink Partners
    4/15/2025$529.00Outperform → Neutral
    Robert W. Baird
    3/17/2025$450.00Hold → Buy
    Argus
    More analyst ratings

    $ELV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schulman Amy W was granted 218 shares (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    2/3/26 4:42:37 PM ET
    $ELV
    Medical Specialities
    Health Care

    EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 279 shares, decreasing direct ownership by 6% to 4,032 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    2/3/26 4:15:20 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Schulman Amy W

    3 - Elevance Health, Inc. (0001156039) (Issuer)

    1/14/26 4:11:34 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Elevance Health downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Elevance Health from Outperform to Sector Perform and set a new price target of $358.00

    2/3/26 6:49:01 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Elevance Health from Peer Perform to Outperform and set a new price target of $425.00

    1/8/26 8:09:47 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Elevance Health from Buy to Hold and set a new price target of $320.00

    12/19/25 8:44:26 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ELV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

    4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion 4Q 2025 diluted EPS1 of $2.47; adjusted diluted EPS2 of $3.33 FY 2025 diluted EPS1 of $25.21; adjusted diluted EPS2 of $30.29 Projected FY 2026 GAAP diluted EPS1 to be at least $22.30 Projected FY 2026 adjusted diluted EPS2 to be at least $25.50 Returned $4.1 billion of capital to shareholders in 2025 Reaffirming long-term earnings algorithm; recalibrating segment margin targets Elevance Health, Inc. (NYSE:ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As

    1/28/26 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026

    Elevance Health (NYSE:ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 888-566-0046 - No Access Code (Domestic Replay) 203-369-3677 - No Access Code (International Replay) The replay will be available from 11:30 a.m. EST on January 28, 2026, until the end of the day on Februar

    12/22/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Reflects On The Changed Role of Health Plans

    By simplifying the healthcare experience, improving care coordination, and leveraging data-driven insights, Elevance Health affiliated health plans help members navigate a range of healthcare experiences with greater confidence As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect health, including cancer diagnoses, mental health crises, and unexpected health concerns during pregnancy. From employer-sponsored health insurance to government-sponsored programs, health plans are evolving to better support their members in a broader range of situations that affect health. In partne

    12/12/25 2:00:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Director Devore Susan D. bought $374,580 worth of shares (1,200 units at $312.15), increasing direct ownership by 52% to 3,502 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    8/21/25 4:20:38 PM ET
    $ELV
    Medical Specialities
    Health Care

    President and CEO Boudreaux Gail bought $2,438,951 worth of shares (8,500 units at $286.94), increasing direct ownership by 6% to 151,020 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    7/18/25 1:42:51 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    SEC Filings

    View All

    SEC Form 10-K filed by Elevance Health Inc.

    10-K - Elevance Health, Inc. (0001156039) (Filer)

    2/6/26 2:57:22 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Elevance Health, Inc. (0001156039) (Filer)

    1/28/26 6:03:02 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Elevance Health, Inc. (0001156039) (Filer)

    12/10/25 4:35:16 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Leadership Updates

    Live Leadership Updates

    View All

    Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

    The board of directors of Elevance Health (NYSE:ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises. This appointment reflects Elevance Health's ongoing board refreshment strategy to ensure diverse, independent, and future-focused leadership that aligns with the company's long-term strategy and stakeholders' priorities. "Amy's record of driving innovation, disciplined investment, an

    12/10/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Appoints Nathan Rich Vice President, Investor Relations

    Elevance Health (NYSE:ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company's growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company's executive leadership team and will report directly to Mark Kaye, Executive Vice President and Chief Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves as Chief Financial Officer for Elevance Health's Government Health Benefits business. "Nate brings nearly two decades of expe

    11/4/24 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Former Deputy Commissioner of New York State Department of Health Joins Sheppard Mullin

    Nationally Recognized Healthcare Policy Leader Adam Herbst Strengthens the Firm's Regulatory Capabilities for Clients Across the Post-Acute, Aging and Long-Term Care Sectors Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Adam S. Herbst has joined the firm as a healthcare partner in New York. Most recently, Herbst served as the New York State Department of Health's Deputy Commissioner for Aging and Long Term Care. He is the ninth healthcare partner to join the firm in 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030758975/en/Adam Herbst (Photo: Business Wire) In joining Sheppard Mullin's industry-l

    10/30/24 12:55:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Financials

    Live finance-specific insights

    View All

    Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

    4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion 4Q 2025 diluted EPS1 of $2.47; adjusted diluted EPS2 of $3.33 FY 2025 diluted EPS1 of $25.21; adjusted diluted EPS2 of $30.29 Projected FY 2026 GAAP diluted EPS1 to be at least $22.30 Projected FY 2026 adjusted diluted EPS2 to be at least $25.50 Returned $4.1 billion of capital to shareholders in 2025 Reaffirming long-term earnings algorithm; recalibrating segment margin targets Elevance Health, Inc. (NYSE:ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As

    1/28/26 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026

    Elevance Health (NYSE:ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 888-566-0046 - No Access Code (Domestic Replay) 203-369-3677 - No Access Code (International Replay) The replay will be available from 11:30 a.m. EST on January 28, 2026, until the end of the day on Februar

    12/22/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) (NYSE:ELV), as well as most of its non-Blue-branded subsidiaries. In addition, AM Best has upgraded the FSR to A (Excellent) from A- (Excellent) and the Long-Term ICR to "a+" (Excellent) from "a-" (Excellent) of Wellpoint Life and Health Insurance Company and Wellpoint West Virginia, Inc. These companies collectively are referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of "bbb+"

    12/12/25 11:10:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

    SC 13G/A - Elevance Health, Inc. (0001156039) (Subject)

    11/14/24 1:22:35 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/24 10:02:59 AM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/23 12:37:59 PM ET
    $ELV
    Medical Specialities
    Health Care